Attune Pharmaceuticals
New York, US · Founded 2018 · Delaware corporation · 1 known investors
Founders & leadership
AT
Adam TomasiNamed on SEC filing
AM
Andrew McDonaldNamed on SEC filing
JB
Jason BablakNamed on SEC filing
Board
RW
Investors · 1
Reported raises · per SEC filings
Form D private placements$23.3M disclosed across 1 round · 2018
▶$23.3MraisedJun 2018 · 11 investors · PharmaceuticalsRule 506(b)
▶$23.3MraisedJun 2018 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Adam TomasiDirector
- Roderick WongDirector
- Andrew McDonaldExecutive Officer, Director
- Jason BablakExecutive Officer
- Offering amount
- $23.6M
- Amount sold
- $23.3M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Attune Pharmaceuticals's investors?
- Attune Pharmaceuticals's investors include RTW Investments L.P..
- How much funding has Attune Pharmaceuticals raised?
- Attune Pharmaceuticals has disclosed $23.3M raised across 1 round.
- Where is Attune Pharmaceuticals headquartered?
- Attune Pharmaceuticals is headquartered in New York, US.